"Welcome to SSJ Finance"

Profit & Loss Accounts

Quarterly Results

Cohance Lifesciences Ltd
Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln	Chairman : Vivek Sharma
Home : Indian Private	Book Value: 115.2528864
BSE Code : 543064	Market Cap: 17140.92
NSE Code : COHANCE	P / E : 46.19

Change Company :

Quarters:

(Rs in Cr.)

Quarterly Results

Particulars	Sep 2025	Jun 2025	Mar 2025	Dec 2024
Type	2Qtr	1Qtr	4Qtr	3Qtr
Net Sales	497.79	483.58	768.57	284.27
Other Income	26.30	13.10	8.19	15.50
Total Income	524.09	496.68	776.76	299.77
Total Expenditure	366.93	387.48	561.58	171.05
Operating Profit	157.16	109.20	215.18	128.72
Interest	5.24	6.80	7.00	2.62
Gross Profit	151.92	102.40	208.18	126.10
Depreciation	31.20	31.36	42.58	14.88
Tax	26.21	18.15	30.74	41.79
Deferred Tax	0.22	0.32	12.09	-14.24
Reported Profit After Tax	94.29	52.57	122.77	83.67

SSJ FINANCE & SECURITIES PRIVATE LIMITED:
1st Floor, Merchant Chamber, Opp. Patkar Hall, 41, New Marine Lines, Mumbai – 400 020
SEBI Regn. Number: INZ000178436 | CDSL: IN-DP-109-2015 | ARN: 40860 | CIN: U67120MH1996PTC104822

SSJ COMMODITIES PRIVATE LIMITED:
SEBI Regn. Number: INZ000013439 | CIN: U51909MH2003PTC140481|Research Analyst SEBI Reg. No.INH000001527

Content powered by Capital Market Charts are powered by TradingView